Journal ArticleClin Cancer Res · October 3, 2024
BACKGROUND: The combination of gemcitabine and docetaxel is often used to treat patients with recurrent osteosarcoma. Nab-paclitaxel has preclinical activity against osteosarcoma and is potentially less myelosuppressive than docetaxel. We conducted a prosp ...
Full textLink to itemCite
Journal ArticleJ Surg Res · November 2023
INTRODUCTION: Treatment for pediatric solid tumors is often intense and multidisciplinary and can create a substantial financial burden for families. Assessing these burdens, termed the financial toxicity of treatment, can be difficult. Using Wilms tumor a ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · June 19, 2023
BACKGROUND AND OBJECTIVES: New childhood cancer diagnoses require timely, complex care coordination and cause considerable logistic burden for families. We used renal tumors as a model to examine healthcare utilization and cost following new solid tumor di ...
Full textLink to itemCite
Journal ArticleJ Pediatr Surg · June 2023
BACKGROUND: Perioperative nutrition is a critical component of appropriate healing and recovery after surgery. We sought to identify perioperative risk in children with cancer and low preoperative hypoalbuminemia undergoing surgical intervention. METHODS: ...
Full textLink to itemCite
Journal ArticleAJR Am J Roentgenol · March 2023
BACKGROUND. In current clinical practice, thyroid nodules in children are generally evaluated on the basis of radiologists' overall impressions of ultrasound images. OBJECTIVE. The purpose of this article is to compare the diagnostic performance of radiolo ...
Full textLink to itemCite
Journal ArticleEMBO molecular medicine · November 2022
Glycogen dysregulation is a hallmark of aging, and aberrant glycogen drives metabolic reprogramming and pathogenesis in multiple diseases. However, glycogen heterogeneity in healthy and diseased tissues remains largely unknown. Herein, we describe a method ...
Full textCite
Journal ArticleNeuro Oncol · January 5, 2022
BACKGROUND: Diffuse intrinsic pontine gliomas (DIPG) generally occur in young school-age children, although can occur in adolescents and young adults. The purpose of this study was to describe clinical, radiological, pathologic, and molecular characteristi ...
Full textLink to itemCite
Journal ArticleJournal of oncology navigation & survivorship · October 2021
BackgroundInfertility is a common late effect for cancer survivors. Whereas assisted reproductive technology has made it possible for survivors to take steps to preserve fertility before starting treatment, only a minority of patients proceed with ...
Cite
Journal ArticlePediatr Blood Cancer · August 2021
Adjuvant chemotherapy for osteosarcoma and Ewing sarcoma consists of conventional cytotoxic regimens that have changed little over the past decades. There is an urgent need for agents that are more effective and have less long-term toxicity. Receptor tyros ...
Full textLink to itemCite
Journal ArticleCancers (Basel) · July 14, 2021
Receptor tyrosine kinases are critical for the growth and proliferation of many different cancers and therefore represent a potential vulnerability that can be therapeutically exploited with small molecule inhibitors. Over forty small molecule inhibitors a ...
Full textLink to itemCite
Journal ArticleTranslational Andrology and Urology · October 1, 2020
Urologic tumors make up approximately 10% of all pediatric cancers, and include a variety of different histologies and imaging considerations. In this review, we discuss standard radiologic approaches for children with tumors arising in the genitourinary s ...
Full textCite
Journal ArticlePediatr Blood Cancer · July 2020
BACKGROUND: The combination of gemcitabine and docetaxel is often used to treat patients with recurrent sarcoma. Nab-paclitaxel is a taxane modified to improve drug exposure and increase intratumoral accumulation and, in combination with gemcitabine, is st ...
Full textLink to itemCite
Journal ArticleOnco Targets Ther · 2019
Although many patients with newly diagnosed Ewing sarcoma can become long-term survivors, relapse remains an important clinical problem for which there is no standard approach. Several prognostic factors have been identified, and these may help guide patie ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · September 2018
Osteosarcoma is the most common bone tumor in children and young adults, with few advances in survival and treatment, especially for metastatic disease, in the last 30 years. Recently, immunotherapy has begun to show promise in various adult cancers, but t ...
Full textLink to itemCite
Journal ArticlePediatr Blood Cancer · May 2018
Young children with emaciation caused by a hypothalamic glioma are considered to have diencephalic syndrome (DS), which is often poorly controlled with conventional treatment. We describe an infant with DS whose tumor progressed following chemotherapy. Bio ...
Full textLink to itemCite
Journal ArticleChilds Nerv Syst · August 2015
PURPOSE: Amplification and high levels of NOTCH ligand expression have been identified in several types of pediatric brain tumors. A phase I trial of weekly MK-0752, an oral inhibitor of gamma-secretase, was conducted in children with recurrent central ner ...
Full textLink to itemCite
Journal ArticleClin Sarcoma Res · 2015
Over the past 15 years, irinotecan has emerged as an important agent for treating pediatric sarcoma patients. This review summarizes the activity noted in previous studies, and outlines current issues regarding scheduling, route of administration, and amel ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · September 15, 2007
PURPOSE: The combination of temozolomide and irinotecan has preclinical schedule-dependent synergy against neuroblastoma but is not curative for relapsed high-risk patients. We hypothesized that the DNA repair protein methylguanine-DNA methyltransferase (M ...
Full textLink to itemCite